Jean Mancheno examines the U.S. Department of Health and Human Services' restructuring and workforce reductions, outlining how the consolidation of agencies and significant staffing cuts could affect key health care stakeholders, including providers, Medicare Advantage plans and life sciences companies. She discusses the potential operational and regulatory impacts of changes across HHS agencies such as the FDA, CDC and CMS, noting that reductions in personnel and leadership may influence policy development, oversight and agency responsiveness. She emphasizes that health care organizations should closely monitor the restructuring and prepare for evolving compliance, regulatory and operational challenges as the changes continue to unfold.